AU617318B2 - Outer membrane protein f of pseudomonas aeruginosa - Google Patents

Outer membrane protein f of pseudomonas aeruginosa

Info

Publication number
AU617318B2
AU617318B2 AU16977/88A AU1697788A AU617318B2 AU 617318 B2 AU617318 B2 AU 617318B2 AU 16977/88 A AU16977/88 A AU 16977/88A AU 1697788 A AU1697788 A AU 1697788A AU 617318 B2 AU617318 B2 AU 617318B2
Authority
AU
Australia
Prior art keywords
pseudomonas aeruginosa
membrane protein
outer membrane
ompf
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU16977/88A
Other versions
AU1697788A (en
Inventor
Horst Domdey
Michael Duchene
Friedrich Lottspeich
Bernd-Ulrich Von Specht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU1697788A publication Critical patent/AU1697788A/en
Application granted granted Critical
Publication of AU617318B2 publication Critical patent/AU617318B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)

Abstract

The gene for outer membrane protein F (OMPF) of Pseudomonas aeruginosa has been isolated, sequenced and expressed to produce OMPF and immunogenic part-sequences in the amount and purity necessary for use for the preparation of vaccines.
AU16977/88A 1987-06-03 1988-06-02 Outer membrane protein f of pseudomonas aeruginosa Ceased AU617318B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873718591 DE3718591A1 (en) 1987-06-03 1987-06-03 AEUSSERES MEMBRANE PROTEIN F BY PSEUDOMONAS AERUGINOSA
DE3718591 1987-06-03

Publications (2)

Publication Number Publication Date
AU1697788A AU1697788A (en) 1988-12-08
AU617318B2 true AU617318B2 (en) 1991-11-28

Family

ID=6328966

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16977/88A Ceased AU617318B2 (en) 1987-06-03 1988-06-02 Outer membrane protein f of pseudomonas aeruginosa

Country Status (7)

Country Link
EP (1) EP0297291B1 (en)
JP (5) JPS6485086A (en)
AT (1) ATE95564T1 (en)
AU (1) AU617318B2 (en)
CA (1) CA1341015C (en)
DE (2) DE3718591A1 (en)
ES (1) ES2059436T3 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8900670A (en) * 1989-03-17 1990-10-16 Stichting Tech Wetenschapp POLYNUCLEOTIDE PROBE, METHOD AND KIT FOR IDENTIFYING AND DETECTING GRAM-NEGATIVE BACTERIA.
WO1993024636A1 (en) * 1992-05-29 1993-12-09 The University Of British Columbia Use of protein oprf for bacterial cell surface expression of oligopeptides
US20020055101A1 (en) 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US6001564A (en) * 1994-09-12 1999-12-14 Infectio Diagnostic, Inc. Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
DE69515613T2 (en) 1994-12-16 2000-11-30 Chiron Behring Gmbh & Co. Immunogenic hybrid protein OprF-Oprl available from membrane proteins from Pseudomonas aeruginosa
US5994066A (en) * 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US20030049636A1 (en) 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
KR100461710B1 (en) * 1997-09-13 2005-09-28 씨제이 주식회사 Novel Pseudomonas aeruginosa cell membrane protein gene and vaccine for preventing Pseudomonas aeruginosa infection using the same
GB9915044D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
JP2003511015A (en) 1999-09-28 2003-03-25 インフェクティオ ダイアグノスティク（アイ．ディー．アイ．）インコーポレイティド Generating highly conserved genes, as well as species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers, algae, archaea, bacteria, fungi from diagnostic clinical specimens And their use for rapid detection and identification of parasite microorganisms
EP1790659B1 (en) 2001-11-13 2013-07-31 ID Biomedical Corporation Polypeptides of pseudomonas aeruginosa
EP1458752A2 (en) 2001-11-13 2004-09-22 Shire Biochem Inc. Polypeptides of pseudomonas aeruginosa
EP3345617B1 (en) 2012-11-30 2020-08-26 GlaxoSmithKline Biologicals S.A. Pseudomonas antigens and antigen combinations
WO2017005670A1 (en) 2015-07-04 2017-01-12 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
WO2018127545A1 (en) 2017-01-05 2018-07-12 Evaxion Biotech Aps Vaccines targeting pseudomonas aeruginosa

Also Published As

Publication number Publication date
EP0297291A3 (en) 1989-03-29
DE3718591A1 (en) 1988-12-15
ES2059436T3 (en) 1994-11-16
DE3884680D1 (en) 1993-11-11
EP0297291A2 (en) 1989-01-04
JP2006187286A (en) 2006-07-20
AU1697788A (en) 1988-12-08
JP2003289889A (en) 2003-10-14
ATE95564T1 (en) 1993-10-15
JP2002165593A (en) 2002-06-11
JPS6485086A (en) 1989-03-30
EP0297291B1 (en) 1993-10-06
CA1341015C (en) 2000-06-06
JP2000074922A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
AU617318B2 (en) Outer membrane protein f of pseudomonas aeruginosa
EP0217580A3 (en) Therapeutic nucleosides
AU567257B2 (en) Sucralfat-suspension
EP1013284A3 (en) Purified forms of dnase
AU1170588A (en) Methods and deoxyribonucleic acid for the preparation of tissue factor protein
HK14294A (en) Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid
AU5612686A (en) Aids antigen, diagnosis and immunogenic compositions
AU7073087A (en) Thiolactam-N-acetic acid derivatives, their production and use
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
WO1996034964A3 (en) Stable variant hk2 polypeptide
AU5185886A (en) Stable dispersions of polyureas and/or polyhydrazodi- carbonamides in relatively high molecular weight, hydroxyl group containing compounds, process for the production thereof and use thereof for the production of polyurethanes
EP0338410A3 (en) Escherichia coli secretor mutants
WO1991015512A3 (en) Hiv envelope polypeptides
IL91184A0 (en) N-2,3-butadienyl tri-and tetraaminoalkane derivatives
AU1907992A (en) Pharmaceutical enema preparation
MY103362A (en) Production of proteins in active forms
ES2004099A6 (en) Use of biologically active polypeptides and compositions containing them.
AU2458988A (en) The preparation, by genetic manipulation, of anticoagulative protein pp4
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
AU4016089A (en) The expression of homologous and heterologous proteins, which are able to function, on the outer membrane of e. coli and other gram-negative bacteria
AU1887988A (en) Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
WO1987001698A3 (en) 1,4-naphthalenediol and 1,4-hydroquinone derivatives
DE3279949D1 (en) Novel microorganisms of the genus eschericia, hybrid dna for use in their production and the use of the microorganisms in the preparation of glutathione
AU7633987A (en) The use of 15-deoxyspergualine as a pharmaceutical
AU1321988A (en) The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein